Issue

Journal Browser
Forthcoming Issue
Current Issue
Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.
Volume 13, Issue 5 (January 2008)
Mosaic serine proteases in the mammalian central nervous system
Front. Biosci. 2008, 13(5), 1991–2000; https://doi.org/10.2741/2818
Role of progesterone and progestin therapy in threatened abortion and preterm labour
Front. Biosci. 2008, 13(5), 1981–1990; https://doi.org/10.2741/2817
The VesiVax system: a method for rapid vaccine development
Front. Biosci. 2008, 13(5), 1968–1980; https://doi.org/10.2741/2816
Cancer targeting using tumor suppressor genes
Front. Biosci. 2008, 13(5), 1959–1967; https://doi.org/10.2741/2815
Dendritic cell based personalized immunotherapy based on cancer antigen research
Front. Biosci. 2008, 13(5), 1952–1958; https://doi.org/10.2741/2814
NK4 gene therapy targeting HGF-Met and angiogenesis
Front. Biosci. 2008, 13(5), 1943–1951; https://doi.org/10.2741/2813
Splicing fidelity, enhancers, and disease
Front. Biosci. 2008, 13(5), 1926–1942; https://doi.org/10.2741/2812
MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2
MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2
Front. Biosci. 2008, 13(5), 1917–1925; https://doi.org/10.2741/2811
The optokinetic response in zebrafish and its applications
Front. Biosci. 2008, 13(5), 1899–1916; https://doi.org/10.2741/2810
Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen
Front. Biosci. 2008, 13(5), 1892–1898; https://doi.org/10.2741/2809
Vector-producing tumor-tracking multipotent mesenchymal stromal cells for suicide cancer gene therapy
Front. Biosci. 2008, 13(5), 1887–1891; https://doi.org/10.2741/2808
Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents
Front. Biosci. 2008, 13(5), 1881–1886; https://doi.org/10.2741/2807
Fish and frogs: models for vertebrate cilia signaling
Front. Biosci. 2008, 13(5), 1866–1880; https://doi.org/10.2741/2806
Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer
Front. Biosci. 2008, 13(5), 1857–1865; https://doi.org/10.2741/2805
Subarachnoid hemorrhage: effect on cerebral blood flow and cerebral metabolism
Front. Biosci. 2008, 13(5), 1845–1856; https://doi.org/10.2741/2804
Posterior circulation stroke and animal models
Front. Biosci. 2008, 13(5), 1827–1844; https://doi.org/10.2741/2803
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Front. Biosci. 2008, 13(5), 1813–1826; https://doi.org/10.2741/2802
Chemical and biochemical oxidations in spinal fluid after subarachnoid hemorrhage
Front. Biosci. 2008, 13(5), 1806–1812; https://doi.org/10.2741/2801
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
Front. Biosci. 2008, 13(5), 1795–1805; https://doi.org/10.2741/2800
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes
Front. Biosci. 2008, 13(5), 1780–1794; https://doi.org/10.2741/2799
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26
Front. Biosci. 2008, 13(5), 1774–1779; https://doi.org/10.2741/2798
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Dipeptidyl peptidase IV inhibitors and diabetes therapy
Front. Biosci. 2008, 13(5), 1753–1773; https://doi.org/10.2741/2797
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
An overview of responsive MRI contrast agents for molecular imaging
Front. Biosci. 2008, 13(5), 1733–1752; https://doi.org/10.2741/2796
Site-specifically modified fusion proteins for molecular imaging
Front. Biosci. 2008, 13(5), 1716–1732; https://doi.org/10.2741/2795
Microneedles for transdermal drug delivery: a minireview
Front. Biosci. 2008, 13(5), 1711–1715; https://doi.org/10.2741/2794
Steroids and nitric oxide in sepsis
Front. Biosci. 2008, 13(5), 1698–1710; https://doi.org/10.2741/2793
Interventional neurophysiology: A new frontier in investigation, treatment and research
Interventional neurophysiology: A new frontier in investigation, treatment and research
Front. Biosci. 2008, 13(5), 1691–1697; https://doi.org/10.2741/2792
Alternative splicing of U12-type introns
Front. Biosci. 2008, 13(5), 1681–1690; https://doi.org/10.2741/2791
Mechanical stimulation of primary cilia
Front. Biosci. 2008, 13(5), 1665–1680; https://doi.org/10.2741/2790
Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease
Front. Biosci. 2008, 13(5), 1654–1664; https://doi.org/10.2741/2789
Genetics and development of the optic chiasm
Front. Biosci. 2008, 13(5), 1646–1653; https://doi.org/10.2741/2788
The role of CD26/dipeptidyl peptidase IV in cancer
Front. Biosci. 2008, 13(5), 1634–1645; https://doi.org/10.2741/2787
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Humanization of antibodies
Front. Biosci. 2008, 13(5), 1619–1633; https://doi.org/10.2741/2786
Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor
Front. Biosci. 2008, 13(5), 1610–1618; https://doi.org/10.2741/2785
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Nelfinavir monotherapy increases naïve T-cell numbers in HIV-negative healthy young adults
Front. Biosci. 2008, 13(5), 1605–1609; https://doi.org/10.2741/2784
Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.
Volume 13, Issue 5 (2008)

Journal Browser
Forthcoming Issue
Current Issue
Article
Mosaic serine proteases in the mammalian central nervous system
Front. Biosci. 2008, 13(5), 1991–2000; https://doi.org/10.2741/2818
Role of progesterone and progestin therapy in threatened abortion and preterm labour
Front. Biosci. 2008, 13(5), 1981–1990; https://doi.org/10.2741/2817
The VesiVax system: a method for rapid vaccine development
Front. Biosci. 2008, 13(5), 1968–1980; https://doi.org/10.2741/2816
Cancer targeting using tumor suppressor genes
Front. Biosci. 2008, 13(5), 1959–1967; https://doi.org/10.2741/2815
Dendritic cell based personalized immunotherapy based on cancer antigen research
Front. Biosci. 2008, 13(5), 1952–1958; https://doi.org/10.2741/2814
NK4 gene therapy targeting HGF-Met and angiogenesis
Front. Biosci. 2008, 13(5), 1943–1951; https://doi.org/10.2741/2813
Splicing fidelity, enhancers, and disease
Front. Biosci. 2008, 13(5), 1926–1942; https://doi.org/10.2741/2812
MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2
MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2
Front. Biosci. 2008, 13(5), 1917–1925; https://doi.org/10.2741/2811
The optokinetic response in zebrafish and its applications
Front. Biosci. 2008, 13(5), 1899–1916; https://doi.org/10.2741/2810
Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen
Front. Biosci. 2008, 13(5), 1892–1898; https://doi.org/10.2741/2809
Vector-producing tumor-tracking multipotent mesenchymal stromal cells for suicide cancer gene therapy
Front. Biosci. 2008, 13(5), 1887–1891; https://doi.org/10.2741/2808
Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents
Front. Biosci. 2008, 13(5), 1881–1886; https://doi.org/10.2741/2807
Fish and frogs: models for vertebrate cilia signaling
Front. Biosci. 2008, 13(5), 1866–1880; https://doi.org/10.2741/2806
Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer
Front. Biosci. 2008, 13(5), 1857–1865; https://doi.org/10.2741/2805
Subarachnoid hemorrhage: effect on cerebral blood flow and cerebral metabolism
Front. Biosci. 2008, 13(5), 1845–1856; https://doi.org/10.2741/2804
Posterior circulation stroke and animal models
Front. Biosci. 2008, 13(5), 1827–1844; https://doi.org/10.2741/2803
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Front. Biosci. 2008, 13(5), 1813–1826; https://doi.org/10.2741/2802
Chemical and biochemical oxidations in spinal fluid after subarachnoid hemorrhage
Front. Biosci. 2008, 13(5), 1806–1812; https://doi.org/10.2741/2801
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
Front. Biosci. 2008, 13(5), 1795–1805; https://doi.org/10.2741/2800
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes
Front. Biosci. 2008, 13(5), 1780–1794; https://doi.org/10.2741/2799
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26
Front. Biosci. 2008, 13(5), 1774–1779; https://doi.org/10.2741/2798
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Dipeptidyl peptidase IV inhibitors and diabetes therapy
Front. Biosci. 2008, 13(5), 1753–1773; https://doi.org/10.2741/2797
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
An overview of responsive MRI contrast agents for molecular imaging
Front. Biosci. 2008, 13(5), 1733–1752; https://doi.org/10.2741/2796
Site-specifically modified fusion proteins for molecular imaging
Front. Biosci. 2008, 13(5), 1716–1732; https://doi.org/10.2741/2795
Microneedles for transdermal drug delivery: a minireview
Front. Biosci. 2008, 13(5), 1711–1715; https://doi.org/10.2741/2794
Steroids and nitric oxide in sepsis
Front. Biosci. 2008, 13(5), 1698–1710; https://doi.org/10.2741/2793
Interventional neurophysiology: A new frontier in investigation, treatment and research
Interventional neurophysiology: A new frontier in investigation, treatment and research
Front. Biosci. 2008, 13(5), 1691–1697; https://doi.org/10.2741/2792
Alternative splicing of U12-type introns
Front. Biosci. 2008, 13(5), 1681–1690; https://doi.org/10.2741/2791
Mechanical stimulation of primary cilia
Front. Biosci. 2008, 13(5), 1665–1680; https://doi.org/10.2741/2790
Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease
Front. Biosci. 2008, 13(5), 1654–1664; https://doi.org/10.2741/2789
Genetics and development of the optic chiasm
Front. Biosci. 2008, 13(5), 1646–1653; https://doi.org/10.2741/2788
The role of CD26/dipeptidyl peptidase IV in cancer
Front. Biosci. 2008, 13(5), 1634–1645; https://doi.org/10.2741/2787
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Humanization of antibodies
Front. Biosci. 2008, 13(5), 1619–1633; https://doi.org/10.2741/2786
Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor
Front. Biosci. 2008, 13(5), 1610–1618; https://doi.org/10.2741/2785
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Nelfinavir monotherapy increases naïve T-cell numbers in HIV-negative healthy young adults
Front. Biosci. 2008, 13(5), 1605–1609; https://doi.org/10.2741/2784
